post image

Pfizer stocks soar as bionTech stocks tumble: BionTech

BION Tech, a biotechnology company based in the US, said Wednesday it was in the red on Tuesday after news that Pfizer and its drugmaker rival AstraZeneca had pulled out of its deal to develop a drug for hepatitis C.BionTech said its shares plunged as much as 13% to $2.29 in the afternoon after Pfizer